Cancer is the largest cause of death in the world, with millions of new cases and deaths occurring each year. While cancer screening can aid in the early detection and treatment of cancer, many people, particularly in low- and middle-income countries, lack access to such services. The Worldwide Cancer Screening Project (GCSP) was established in 2017 to address this worldwide health issue.
On the GCSP website, you can learn about the project's goals, activities, partners, and resources. You can also find the most recent cancer screening and prevention news, events, and publications. For example, you might learn about the recent establishment of a GCSP hub in India, which intends to improve cancer screening and research in the country and worldwide.
Furthermore, the GCSP website includes resources and tools for implementing effective and equitable cancer screening programs, such as the IARC Handbook of Cancer Prevention, the UICC Cervical Cancer Screening Framework, and the WHO Cancer Screening Principles. These resources can assist policymakers, healthcare professionals, researchers, and advocates in developing, implementing, and evaluating cancer screening programs that are tailored to local requirements and goals.
To summarize, the GCSP is an important program that contributes to global efforts to reduce cancer burden through early identification and prevention. Explore the GCSP website to learn more about this project and how you can help advance cancer screening globally.
Clinical trials are currently being offered at the University of Arkansas for Medical Sciences (UAMS). Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single… Read More »
Clinical trials are currently being offered at the University of Alabama at Birmingham. Immunotherapy has gained a significant amount of attention recently, but its efficacy as a single agent in… Read More »
Clinical trials are currently being offered at Medical University of South Carolina (MUSC) Health Care in Charleston SC. A Phase II/III Study of Paciltaxel/Carboplatin alone, or combined with either Trastuzumab… Read More »